Kailera Therapeutics Inc

NAS:KLRAHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$12.89+12.77%At closeAt close · Wed 21 Oct · ≈ AED 47.34 · Market cap $1.67B · Next earnings Wed 2 Dec

Kailera Therapeutics Inc · Ownership · TradingHolo

Open-market trades from Form 4 filings

Insiders bought $326.75M and sold $0 in the filings shown.

Date	Name	Role	Type	Shares	Value
Tue, 9 Jun 2026	Renaud Ronald C JR	director, officer: CEO & President	M-Exempt	38,094	$199.99K
Mon, 20 Apr 2026	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	10 percent owner	C-Conversion	2,034,133	—
Mon, 20 Apr 2026	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	10 percent owner	C-Conversion	9,477,719	—
Mon, 20 Apr 2026	RTW INVESTMENTS, LP	10 percent owner	P-Purchase	500,000	$8M
Mon, 20 Apr 2026	RTW INVESTMENTS, LP	10 percent owner	C-Conversion	10,276,820	—
Mon, 20 Apr 2026	BCLS Fund IV Investments GP, LLC	10 percent owner	C-Conversion	16,875,000	—
Mon, 20 Apr 2026	BCLS Fund IV Investments GP, LLC	10 percent owner	P-Purchase	1,562,500	$25M
Mon, 20 Apr 2026	BCLS Fund IV Investments GP, LLC	10 percent owner	C-Conversion	4,145,768	—
Mon, 20 Apr 2026	Koppel Adam	director, 10 percent owner	P-Purchase	1,562,500	$25M
Mon, 20 Apr 2026	Koppel Adam	director, 10 percent owner	C-Conversion	16,875,000	—
Mon, 20 Apr 2026	Koppel Adam	director, 10 percent owner	C-Conversion	4,145,768	—
Mon, 20 Apr 2026	BCPE Perseus Investor, LP	10 percent owner	P-Purchase	8,398,438	$134.38M
Mon, 20 Apr 2026	BCPE Perseus Investor, LP	10 percent owner	C-Conversion	17,857,143	—
Mon, 20 Apr 2026	Kaplan Andrew T.	director, 10 percent owner	P-Purchase	8,398,438	$134.38M
Mon, 20 Apr 2026	Kaplan Andrew T.	director, 10 percent owner	C-Conversion	17,857,143	—

From 13F filings · Tue, 30 Jun 2026

Holder	Shares	% out	Change
Bain Capital Investors LLC	26,255,581	20.3%	—
Bain Capital Life Sciences Investors, LLC	22,583,268	17.4%	—
RTW INVESTMENTS, LP	10,776,820	8.3%	—
CANADA PENSION PLAN INVESTMENT BOARD	7,304,688	5.6%	—
Atlas Venture Life Science Advisors, LLC	5,171,282	4.0%	—
FMR LLC	3,970,865	3.1%	—
BlackRock, Inc.	3,928,604	3.0%	—
CITADEL ADVISORS LLC	3,240,787	2.5%	—
ADAGE CAPITAL PARTNERS GP, L.L.C.	3,208,286	2.5%	—
WELLINGTON MANAGEMENT GROUP LLP	2,919,110	2.3%	—
Royalty Pharma Sub-Manager, LLC	2,455,357	1.9%	—
Siren, L.L.C.	2,214,286	1.7%	—
VANGUARD CAPITAL MANAGEMENT LLC	1,693,958	1.3%	—